" /> Cyclophosphamide/Cytarabine/Dexamethasone/Etoposide/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine Regimen - CISMeF





Preferred Label : Cyclophosphamide/Cytarabine/Dexamethasone/Etoposide/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine Regimen;

NCIt synonyms : Cytarabine/Dexamethasone/Pegaspargase/Vincristine/Methotrexate/Mercaptopurine/Cyclophosphamide/Etoposide; Cyclophosphamide-Cytarabine-Dexamethasone-Etoposide-Mercaptopurine-Methotrexate-Pegaspargase-Vincristine; Cyclophosphamide-Cytarabine-Dexamethasone-Etoposide-Mercaptopurine-Methotrexate-Pegaspargase-Vincristine Regimen; Cyclophosphamide/Cytarabine/Dexamethasone/Etoposide/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine;

NCIt definition : A regimen consisting of cyclophosphamide, cytarabine, dexamethasone, etoposide, mercaptopurine, methotrexate, pegaspargase and vincristine that may be used in the treatment of acute lymphoblastic leukemia (ALL).;

NCI Metathesaurus CUI : CL1905536;

Details


You can consult :


Nous contacter.
23/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.